BERARDO, CLARISSA ANGELA IRIS
 Distribuzione geografica
Continente #
NA - Nord America 2.235
AS - Asia 1.513
EU - Europa 1.185
SA - Sud America 237
AF - Africa 66
OC - Oceania 7
Totale 5.243
Nazione #
US - Stati Uniti d'America 2.175
CN - Cina 586
IE - Irlanda 395
SG - Singapore 326
RU - Federazione Russa 212
VN - Vietnam 205
HK - Hong Kong 201
BR - Brasile 174
DE - Germania 125
FR - Francia 94
FI - Finlandia 87
IT - Italia 83
IN - India 42
CA - Canada 40
GB - Regno Unito 40
ZA - Sudafrica 35
BD - Bangladesh 28
BE - Belgio 27
CZ - Repubblica Ceca 27
JP - Giappone 24
SE - Svezia 24
AR - Argentina 23
MX - Messico 17
EC - Ecuador 16
PL - Polonia 14
PK - Pakistan 13
UA - Ucraina 12
ID - Indonesia 11
IQ - Iraq 10
TR - Turchia 10
CO - Colombia 8
ES - Italia 7
NL - Olanda 7
SA - Arabia Saudita 7
EG - Egitto 6
MA - Marocco 6
MY - Malesia 6
PH - Filippine 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
JO - Giordania 5
LT - Lituania 5
UZ - Uzbekistan 5
KR - Corea 4
PY - Paraguay 4
AU - Australia 3
BO - Bolivia 3
CL - Cile 3
DZ - Algeria 3
ET - Etiopia 3
HR - Croazia 3
IL - Israele 3
LV - Lettonia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
IR - Iran 2
RO - Romania 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MM - Myanmar 1
MU - Mauritius 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RE - Reunion 1
SN - Senegal 1
TM - Turkmenistan 1
UY - Uruguay 1
Totale 5.243
Città #
Chandler 427
Dublin 393
San Jose 224
Hong Kong 196
Ashburn 193
Beijing 191
Singapore 162
Dallas 138
Boardman 72
Los Angeles 69
Lauterbourg 66
Helsinki 63
Moscow 60
Princeton 60
Lawrence 58
Hanoi 57
Munich 57
Shanghai 57
Medford 56
Ho Chi Minh City 54
Nanjing 42
New York 37
Pavia 35
Wilmington 35
Johannesburg 30
Buffalo 29
Ann Arbor 27
Brussels 27
Jacksonville 27
Redondo Beach 27
Tokyo 24
Brno 21
Orem 20
São Paulo 19
Hebei 17
Nanchang 17
Montreal 16
Turku 16
Toronto 15
Atlanta 14
Da Nang 14
Changsha 13
Hangzhou 13
Warsaw 13
Tianjin 12
Council Bluffs 11
Frankfurt am Main 11
Haiphong 11
London 11
Mexico City 11
San Francisco 11
Monza 10
Shenyang 10
Chennai 9
Columbus 9
Houston 9
Santa Clara 9
Seattle 9
Denver 8
Düsseldorf 8
Jiaxing 8
Poplar 8
Quito 8
The Dalles 8
Des Moines 7
Fairfield 7
Guayaquil 7
Chicago 6
Dhaka 6
Thái Nguyên 6
Amsterdam 5
Baghdad 5
Belo Horizonte 5
Brooklyn 5
Raleigh 5
Redwood City 5
Rio de Janeiro 5
Amman 4
Berlin 4
Biên Hòa 4
Brasília 4
Brescia 4
Cagliari 4
Campinas 4
Charlotte 4
Dearborn 4
Falls Church 4
Guangzhou 4
Hải Dương 4
Kuala Lumpur 4
Lahore 4
Laurel 4
Mumbai 4
New Delhi 4
Nuremberg 4
Paris 4
Seoul 4
Tashkent 4
Washington 4
Alexandria 3
Totale 3.557
Nome #
Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. 169
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 140
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 132
Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models 128
Changes in biliary levels of arginine and its methylated derivatives after hepatic ischaemia/reperfusion 123
Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma 120
Liver plays a central role in asymmetric dimethylarginine-mediated organ injury 114
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 114
Fluorescing fatty acids in rat fatty liver models 113
Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation 111
Serum and hepatic autofluorescence as a real-time diagnostic tool for early cholestasis assessment 110
Allosteric modulation of mGlu5 receptors by MPEP protects against hepatic cold ischemia and reperfusion injury 110
Analysis of Massaciuccoli Peat after Maturation in Sodium Chloride Water of Undulna Thermae 109
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 104
Fatty liver susceptibility to preservation injury using static cold storage versus dynamic machine perfusion 100
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update 99
Liver graft susceptibility during static cold storage and dynamic machine perfusion: DCD versus fatty livers 98
Fluorescence excitation properties of bilirubin in solution and in serum 98
Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research 96
Increase in transporter MATE-1 expression induced by obeticholic acid correlates with higher biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 95
Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury 92
Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet 92
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV. 91
Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity 89
Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract 88
Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium 88
Spectrofluorometric analysis of autofluorescing components of crude serum from a rat liver model of ischemia and reperfusion 85
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats 85
MPEP, a metabotropic Glutamate Receptor 5 (mGluR5) negative allosteric modulator, protects from hepatic ischemic injury both in vitro and ex vivo. 84
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis 84
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH 83
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 81
MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters 78
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury 78
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats 78
Metabotropic glutamate receptor blockade reduces preservation damage in livers from donors after cardiac death 76
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 76
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice 73
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury 73
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 71
SAT-389-Obeticholic acid reduces matrix metalloproteinases activity via iNOS modulation in hepatic ischemia/reperfusion injury 69
Hepatic ischemic injury decreases using negative allosteric modulators of metabotropic glutamate receptor subtype 5 69
Changes in glutathione content in liver diseases: An update 68
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 68
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 68
Negative allosteric modulators of metabotropic glutamate receptor subtype 5 protect against hepatic ischemia/reperfusion injury 68
NAD(P)H and Flavin Autofluorescence Correlation with ATP in Rat Livers with Different Metabolic Steady-State Conditions 67
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 67
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats 67
P0006 : Hepatic ischemia/reperfusion induces changes in tissue and biliary levels of arginine and its methylated derivatives 66
Selective Blockade of Metabotropic Glutamate Receptor by MPEP Protects against Hepatic Cold Ischemia and Reperfusion Injury 66
MPEP administration reduces steatosis and inflammation in ob/ob mice 66
Lobe-specific oxidative stress and matrix metalloproteinase activation in two animal models of non-alcoholic fatty liver disease (NAFLD) 63
Machine perfusion at 20°C prevents ischemic injury and reduces hypoxia-inducible factor-1α expression during rat liver preservation 62
Further increase in biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury by obeticholic acid, a farnesoid-X-receptor agonist 61
The Effect of Healthy Lifestyle Strategies on the Management of Insulin Resistance in Children and Adolescents with Obesity: A Narrative Review 57
Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD 57
The Farnesoid-X-Receptor Agonist Obeticholic Acid Further Increases Biliary Excretion of Asymmetric Dimethylarginine during Hepatic Ischemia/Reperfusion Injury 56
Upregulation of MATE-1 transporter by obeticholic acid correlates with increased biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 51
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 50
Use of Physical Activity and Exercise to Reduce Inflammation in Children and Adolescents with Obesity 46
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 46
Innovative targets involved in the progression of NASH: Asymmetric-dymethylarginine (ADMA) and its cationic transporters 40
Metalloproteinases activation involvement in the progression of liver injury from NAFLD to NASH 35
Totale 5.361
Categoria #
all - tutte 23.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.433


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 6 5 1
2021/2022299 1 3 4 2 6 3 3 25 5 8 97 142
2022/20231.134 129 104 11 127 60 117 7 55 464 12 34 14
2023/2024364 66 43 15 18 34 69 41 23 0 15 10 30
2024/20251.048 20 73 20 21 20 70 87 26 282 56 128 245
2025/20262.121 164 146 256 255 304 104 438 95 205 154 0 0
Totale 5.361